Induction of dopaminergic neuronal-like cells from CD44 + human amniotic fluids that are ameliorative to behavioral recovery in a Parkinson's disease rat model

International Journal of Molecular Medicine

Volumn 28, Issue 5, 2011, Pages 745-752

  Liu, Te ^a,b   Guo, Lihe ^c   Liu, Zhixue ^d   Huang, Yongyi ^e   Cheng, Weiwei ^f  

^a DONGHUA UNIVERSITY   (China)

^b Shanghai Geriatric Institute of Chinese Medicine   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^d TONGJI UNIVERSITY   (China)

^e UNIVERSITÉ DE TOULON   (France)

^f SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cells transplantation; Dopaminergic neurons; Human amniotic fluid cells; Parkinson's disease; Rat model

Indexed keywords

CELL MARKER; HERMES ANTIGEN; OXIDOPAMINE;

AMNIOTIC FLUID CELL; ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL MIGRATION; CELL REGENERATION; CELL SUBPOPULATION; CELL TRANSPLANTATION; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL DIFFERENTIATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

ALKALINE PHOSPHATASE; AMNIOTIC FLUID; ANIMALS; ANTIGENS, CD44; BLOTTING, WESTERN; CELL DIFFERENTIATION; DOPAMINERGIC NEURONS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; OXIDOPAMINE; PARKINSON DISEASE; RATS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 80053092076     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.732     Document Type: Article

References (28)

1. Kim HJ: Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons. Biochim Biophys Acta 1812: 1-11, 2011.
2. Gu S, Huang H, Bi J, Yao Y and Wen T: Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model. Brain Res 1257: 1-9, 2009.
3. Fricker-Gates RA and Gates MA: Stem cell-derived dopamine neurons for brain repair in Parkinson's disease. Regen Med 5: 267-278, 2010.
4. Luo Y, Kuang SY and Hoffer B: How useful are stem cells in PD therapy? Parkinsonism Relat Disord 15 (Suppl 3): S171-S175, 2009.
5. Schwarz SC and Schwarz J: Translation of stem cell therapy for neurological diseases. Transl Res 156: 155-160, 2010.
6. Zhang L, Gu S, Zhao C and Wen T: Combined treatment of neurotrophin- 3 gene and neural stem cells is propitious to functional recovery after spinal cord injury. Cell Transplant 16: 475-481, 2007. (Pubitemid 351448283)
7. Wang L, Wang J, Wu Y, et al: A novel function of dcf1 during the differentiation of neural stem cells in vitro. Cell Mol Neurobiol 28: 887-894, 2008.
8. Fathi F, Altiraihi T, Mowla SJ and Movahedin M: Transplantation of retinoic acid treated murine embryonic stem cells & behavioural deficit in Parkinsonian rats. Indian J Med Res 131: 536-544, 2010.
9. Shi Y, Sun G, Zhao C and Stewart R: Neural stem cell self-renewal. Crit Rev Oncol Hematol 65: 43-53, 2008. (Pubitemid 350216477)
10. Bjorklund LM, Sanchez-Pernaute R, Chung S, et al: Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99: 2344-2349, 2002. (Pubitemid 34169063)
11. Hoehn M, Kustermann E, Blunk J, et al: Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 99: 16267-16272, 2002. (Pubitemid 35462784)
12. Chen L, He DM and Zhang Y: The differentiation of human placenta-derived mesenchymal stem cells into dopaminergic cells in vitro. Cell Mol Biol Lett 14: 528-536, 2009.
13. Prusa AR, Marton E, Rosner M, et al: Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 18: 1489-1493, 2003. (Pubitemid 36840959)
14. Kaviani A, Perry TE, Dzakovic A, Jennings RW, Ziegler MM and Fauza DO: The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 36: 1662-1665, 2001. (Pubitemid 33021987)
15. De Coppi P, Bartsch G Jr, Siddiqui MM, et al: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-106, 2007. (Pubitemid 46087908)
16. De Coppi P: C-kit/CD117 cells from amniotic fluid and membranes and their cardiomyogenic potential. Circ Res 107: e11-e12.
17. Roubelakis MG, Bitsika V, Zagoura D, et al: In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med: Sep 27, 2010 (Epub ahead of print), doi: 10.1111/j.1582-4934.2010.01180.x.
18. Karlmark KR, Freilinger A, Marton E, Rosner M, Lubec G and Hengstschlager M: Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells. Int J Mol Med 16: 987-992, 2005.
19. Lin HT, Chiou SH, Kao CL, et al: Characterization of pancreatic stem cells derived from adult human pancreas ducts by fluorescence activated cell sorting. World J Gastroenterol 12: 4529-4535, 2006.
20. Park SB, Seo MS, Kang JG, Chae JS and Kang KS: Isolation and characterization of equine amniotic fluid-derived multipotent stem cells. Cytotherapy 13: 341-349, 2011.
21. Hauser PV, De Fazio R, Bruno S, et al: Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol 177: 2011-2021, 2010.
22. Tsai MS, Lee JL, Chang YJ and Hwang SM: Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19: 1450-1456, 2004.
23. Bossolasco P, Montemurro T, Cova L, et al: Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 16: 329-336, 2006.
24. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al: Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102: 1548-1549, 2003. (Pubitemid 36988070)
25. Li C, Zhou J, Shi G, et al: Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet 18: 4340-4349, 2009.
26. Liu T, Xu F, Du X, et al: Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1. Mol Cell Biochem 340: 265-273, 2010.
27. Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C and Kahn M: Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc Natl Acad Sci USA 104: 5668-5673, 2007. (Pubitemid 47175738)
28. Liu T, Wu J, Huang Q, et al: Human amniotic epithelial cells ameliorate behavioral dysfunction and reduce infarct size in the rat middle cerebral artery occlusion model. Shock 29: 603-611, 2008. (Pubitemid 351544081)